Today, on World Malaria Day 2025, I reaffirm our collective resolve to defeat one of humanity’s most persistent health challenges.
At the Nigeria Natural Medicine Development Agency (NNMDA), we believe that investing in natural medicine research and development is not only strategic but essential to achieving sustainable health outcomes, especially in the fight against malaria.
Our wealth of indigenous knowledge, when combined with cutting-edge scientific innovation, holds immense potential for the prevention, treatment, and management of malaria.
We remain grateful to the House of Representatives of the Federal Republic of Nigeria for their unwavering support and belief in the power of natural medicine to transform health systems.
I am also proud to announce that four innovative NNMDA products, rooted in natural medicine are now ready for uptake. This marks a bold step forward in our commitment to provide effective, homegrown solutions to pressing health challenges.
The fight against malaria demands rethinking, collaboration, and innovation. At NNMDA, we are harnessing the best of modern science and nature’s wisdom to protect lives and shape a healthier Nigeria.
A malaria-free Nigeria is not just a dream, it is possible.
We are coming!

Tea based therapy to effectively reduce parasitemia, associated fever and increase the appetite of persons suffering from malaria.

Cream based mosquito repellant to reduce man-mosquito contact. This product has six hours repellency period. Specially formulated for use at home as well as outdoor. It is recommended specifically for use in the IDPs, for the armed forces and others working in the fields

Dual Action (Indoor Residual Spray) and Air fresher that kills both flying and crawling insects including mosquitoes.

Larvicide Out-Door Spray that controls the breeding of mosquitoes through inhibition of their reproductive stages in stagnant waters thereby reducing malaria infestation. They are at various stages of NAFDAC listing and Patent acquisition process for commercialization.